Physician profile
Andrew J Shapiro
NPI 1437117793
$3,745.74
in general payments reported to CMS, 2019-2025
18 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,316 · 2020: $84.74 · 2021: $51.16 · 2022: $209 · 2023: $367 · 2024: $174 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814 · Gift: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.75 |
| Gift | $270.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,541.15 | 2019-2025 | Da Vinci Surgical System |
| Covidien LP | $334.36 | 2019 | |
| Medtronic, INC. | $154.47 | 2022 | |
| Baxter Healthcare | $149.99 | 2025 | |
| Hologic Sales and Service, LLC | $139.84 | 2025 | 3dimensions |
| Smith+Nephew, INC. | $97.45 | 2019-2023 | Collagenase Santyl |
| Davol INC. | $81.90 | 2025 | Phasix Mesh |
| Mentor Worldwide LLC | $46.56 | 2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Ethicon US, LLC | $43.24 | 2025 | Evarrest, Surgicel Nu-Knit, Vistaseal |
| Cumberland Pharmaceuticals, INC. | $25.31 | 2025 | Caldolor |
| Tela Bio, INC. | $22.79 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hologic INC | $21.44 | 2019 | |
| Merck Sharp & Dohme LLC | $19.83 | 2023 | Bridion |
| Stryker Corporation | $18.65 | 2025 | Molli, Spy-Phi System |
| Medtec LLC | $18.00 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $17.92 | 2021 | |
| Biocompatibles, INC. | $12.84 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.